Feature Channels:
Stem Cells
Filters:
MedicineChannels:Glioblastoma, Cancer, Cancer Stem Cells, Virginia Tech Carilion Research Institute |
Research teams at the Virginia Tech Carilion Research Institute from three colleges — Engineering, Science, and Veterinary Medicine — are developing new approaches to treat glioblastoma, the aggressive form of brain cancer diagnosed in U.S. Sen. John McCain. |
Released: 26-Jul-2017 4:05 PM EDT
Virginia Tech |
MedicineChannels:Cancer, Stem Cells, Prodrug, Metastases |
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a more localized way. |
Released: 26-Jul-2017 2:00 PM EDT
University of California, Irvine |
MedicineChannels:Aging, Cell Biology, Neuro, Stem Cells, Featured: MedWire, Nature (journal), Local - New York, Local - New York Metro, All Journal News, Staff Picks, Grant Funded News Aging, aging and the brain, hypothalmus, hypothalmic stem cells, Age-related Diseases, extending lifespan, reverse aging, Micrornas, Mirnas |
Scientists at Albert Einstein College of Medicine have found that stem cells in the brain’s hypothalamus govern how fast aging occurs in the body. The finding, made in mice, could lead to new strategies for warding off age-related diseases and extending lifespan. The paper was published online today in Nature. |
Embargo expired: 26-Jul-2017 1:00 PM EDT
Released: 25-Jul-2017 9:00 AM EDT
Albert Einstein College of Medicine |
MedicineChannels:AIDS and HIV, Autoimmune Diseases, Behavioral Science, Biotech, Bone Health, Cell Biology, Chemistry, Children's Health, Infectious Diseases, Men's Health, Mental Health, Military Health, Public Health, Regenerative Medicine, Seniors, Sex and Relationships, Sleep, Stem Cells, Women's Health, Local - Virginia |
Penile Microbiome Study, Latent HIV, Autoimmune Disease Barrier, and More in the AIDS and HIV News SourceThe latest research, features, and experts on HIV and AIDS. |
Released: 26-Jul-2017 7:05 AM EDT
Newswise |
MedicineChannels:breast cancer, breast cancer clinical trials, breast cancer stem cells, cancer stem cells, CK5, lynsey fettig, retinoic acid, retinoids, university of colorado cancer center |
University of Colorado Cancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining failure of retinoic acid trials against breast cancer and offers a possible strategy for their use. |
Released: 25-Jul-2017 4:05 PM EDT
University of Colorado Cancer Center |
MedicineChannels:Biotech, Blood Disorders, Bone Health, Cancer, Cell Biology, Chemistry, Children's Health, Complementary Medicine, Dermatology, Genetics, Healthcare, Immunology, Drug Resistance, Infectious Diseases, Kidney Disease, Men's Health, Mental Health, Military Health, Mindfulness, Neuro, Nursing, Nutrition, OBGYN, Oral Health, Pain, Personalized Medicine, Pharmaceuticals, |
Brain Cancer Experts, Therapy that Targets Cancer Stem Cells, Lung Cancer Hope, and More in the Cancer News SourceClick here to go directly to the Cancer News Source |
Released: 24-Jul-2017 3:25 PM EDT
Newswise |
MedicineChannels:Cardiovascular Health, Heart Disease, Stem Cells, JAMA, All Journal News, Healthcare, Featured: MedWire, Staff Picks Saint Louis University School of Medicine, paul hauptman, Heart Failure, Stem Cells, SLU School of medicine |
Stem cell centers claim to offer effective treatment to patients with heart failure, despite the fact that the treatment is not approved for such use by the U.S. Food and Drug Administration (FDA), says the author of research letter in the current issue of JAMA Internal Medicine. |
Released: 24-Jul-2017 10:05 AM EDT
Saint Louis University Medical Center |
MedicineChannels:Cancer, Immunotherapy, Stem Cells, California Institute For Regenerative Medicine, Cirm, CAR-T cell therapy |
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved a $5.8 million award to University of California San Diego School of Medicine researchers to develop a new immunotherapy in which patients’ cells would be equipped with a special receptor that recognizes and targets cancer stem cells, whose survival abilities often render standard therapies ineffective or short-term. |
Released: 20-Jul-2017 3:05 PM EDT
University of California San Diego Health |
MedicineChannels: |
Glaucoma Recovery, Corneal Inflammation, IRD Trial, and More in the Vision News SourceThe latest research and feature news on vision in the Vision News Source |
Released: 15-Jul-2017 3:15 PM EDT
Newswise |
MedicineChannels:Biomedical Engineering, Stem Cell, Substrate |
UW-Madison researchers have invented an all-chemical replacement for the confusing, even dangerous materials, now used to grow stem cells. |
Released: 14-Jul-2017 2:05 PM EDT
University of Wisconsin-Madison |